| Literature DB >> 32731504 |
Lucia Aidos1, Alessandra Cafiso1, Valentina Serra1, Mauro Vasconi1, Daniela Bertotto2, Chiara Bazzocchi1,3,4, Giuseppe Radaelli2, Alessia Di Giancamillo1.
Abstract
In the present study, a multidisciplinary approach was used in order to evaluate growth, muscle development, and stress status in Siberian sturgeon Acipenser baerii larvae at schooling (T1) and complete yolk sac absorption (T2), reared at three stocking densities (low, medium, and high). Larvae growth, morphological muscle development, and whole-body cortisol levels were assessed. The expression of genes involved in the growth process (igf1 and igf2), in the myogenesis (myog), and in the regulation of cellular stress (glut1, glut2, glut4, and hsp70) was analyzed using a quantitative PCR. Larvae reared at lower densities showed a higher Specific Growth Rate and showed a physiological muscle development. Cortisol levels were low and did not differ significantly, both in different time sampling and across densities, suggesting that either the considered densities are not stressors in this species in the early stages of development or the hypothalamus-pituitary-adrenal (HPA) axis is not yet fully mature. Gene expression of glut1, igf1, and igf2 showed an up-regulation in both developmental stages at all the rearing densities considered, while myog significantly up-regulated at T1 at the highest density. Considering all of the results, it would seem that lower densities should be used in these stages of development, as these showed a higher growth rate, even if it is not economically feasible in commercial hatcheries. Therefore, choosing an intermediate stocking density could be a good compromise between larval performance and economical feasibility.Entities:
Keywords: larvae; muscle development; siberian sturgeon; stocking density; stress
Year: 2020 PMID: 32731504 PMCID: PMC7460203 DOI: 10.3390/ani10081289
Source DB: PubMed Journal: Animals (Basel) ISSN: 2076-2615 Impact factor: 2.752
glut1, glut2, glut4, and igf2 primer sequences, annealing temperatures, and amplification size of each fragment.
| Genes | Primer Forward (5′–3′) | Primer Reverse (5′–3′) | Tm F | Tm R | Fragment Size (bp) |
|---|---|---|---|---|---|
|
| GCTGAAACGCTATGTGGTG | GTGACCTTCGGATGTTTG | 59 | 60 | 109 |
|
| AGCCCATTCCTCCAACCTC | GAGTTTCGCCTCCCAAAGC | 62 | 62 | 124 |
|
| CTATCGTGGTGCCTTGGGA | GCCCCTGACAAGCCCAGAA | 62 | 64 | 132 |
|
| GGCAGCCCATCATCATCGCC | CCACGCCCGCCTTCTCAAAG | 63 | 63 | 105 |
Cumulative mortality rate (%) of Siberian sturgeon larvae reared at different densities at T1 (from T0 to T1) and T2 (from T1 to T2).
| Low-Density | Mid-Density | High-Density | |
|---|---|---|---|
|
| 29.83% ± 1.66 a | 36.50% ± 1.86 b | 35.66% ± 2.35 b |
|
| 0.66% ± 0.35 | 2.0% ± 0.88 | 3.3% ± 2.3 |
Within a row, means with different superscript letters differ significantly (p < 0.05). Absence of superscript indicates no significant difference between treatments. Values are means ± Standard error. Treatment < 0.01; Stage < 0.01; Treatment × Stage < 0.01.
Growth performance of Siberian sturgeon larvae reared at different densities in the time-points T0, T1, and T2.
| Growth Parameters | T0 | Low-Density | Mid-Density | High-Density | |
|---|---|---|---|---|---|
|
| Body Weight mg | 12.65 ± 1.56 | |||
| Total Length mm | 10.5 ± 0.17 | ||||
| Condition Factor | 1.13 ± 0.05 | ||||
|
| Body Weight mg | 24.29 ± 0.92 | 24.08 ± 0.98 | 23.80 ± 0.95 | |
| Total Length mm | 15.35 ± 0.10 | 15.07 ± 0.18 | 15.33 ± 0.20 | ||
| Condition Factor | 0.67 ± 0.03 | 0.71 ± 0.03 | 0.67 ± 0.03 | ||
| Specific Growth Rate | 5.58 ± 0.28 | 5.51 ± 0.30 | 5.43 ± 0.30 | ||
|
| Body Weight mg | 33.01 ± 0.87 a | 30.31 ± 0.74 b | 30.15 ± 0.87 b | |
| Total Length mm | 17.73 ± 0.13 a | 16.96 ± 0.13 b | 17.11 ± 0.16 b | ||
| Condition Factor | 0.59 ± 0.03 | 0.62 ± 0.02 | 0.61 ± 0.03 | ||
| Specific Growth Rate | 3.72 ± 0.10 a | 3.27 ± 0.11 b | 3.36 ± 0.17 b | ||
Within a row means with different superscript letter differ significantly (p < 0.05). Absence of superscript indicates no significant difference between treatments. Values are means ± Standard error. Body Weight: Treatment < 0.01; Stage < 0.01; Treatment × Stage = 0.772. Total Length: Treatment < 0.01; Stage < 0.01; Treatment × Stage = 0.373. SGR: Treatment = 0.243; Stage < 0.01; Treatment × Stage = 0.817. K: Treatment < 0.01; Stage = 0.003; Treatment × Stage = 0.844.
Figure 1Representative images of hematoxylin/eosin (HE) (a–c) and actin immunofluorescence (d–f) at different rearing densities at different time-points: (a,d) at T0; (b,e) at low density (LD) at T1; (c,f) at medium density (MD) at T2. SM, slow muscle cells; FM, fast muscle cells. Green staining, anti-rabbit skeletal muscle actin antibody (ACTA1) immunofluorescence; blue staining, nuclei; asterisks (*), slow muscle; arrow-heads, fast muscle. HE scale bar is located in figure a and refers to 100 µm; actin immunofluorescence scale bars are located in each figure.
Figure 2Whole-body cortisol concentrations expressed as pg per mg of body weight. Error bars indicate the standard error of the mean for each treatment/stage of development.
Figure 3Relative gene expression of: (a) glut1; (b) glut2; (c) glut4, and (d) hsp70; Means with asterisks differ significantly between stages of development (p < 0.05); a,b Means with different superscripts differ significantly between treatments (p < 0.05); red line indicates the up- and down-regulation limit.
Figure 4Relative gene expression of: (a) igf1; (b) igf2; (c) myog; Means with asterisks differ significantly between stages of development (p < 0.05); A,B Means with different superscripts differ significantly between treatments (p < 0.01); a,b Means with different superscripts differ significantly between treatments (p < 0.05); red line indicates the up- and down-regulation limit.